-
September 19, 2022 End of Life: Psychedelics in Palliative CareWe interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics...
-
May 4, 2022 Interview With Daniel Carcillo, Natalie Ginsberg, Olivia Mannix & Klee IrwinThis week on the Psychedelic Spotlight podcast, we provide a recap of the inaugural Benzinga...
-
January 7, 2022 Interview with James Lanthier, CEO of Mindset PharmaCEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the...
-
December 29, 2021 Interview with Matt Stang, CEO of Delic CorpCo-Founder and CEO, Matt Stang, gives us an overview of the company's clinics, Delic Labs...
-
October 19, 2021 Interview with Patrick Moher, CEO of MicrodoseIn this chat, he discusses some of the challenges involved in moving virtual events to...
-
October 7, 2021 Interview with Bright Minds Biosciences’ CEO Ian McDonaldIn today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian...
-
October 6, 2021 Interview with James Lanthier, CEO of Mindset PharmaIn our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when...
-
October 5, 2021 Interview with Ian McDonald, CEO & Director of Bright Minds BiosciencesIn this wide ranging interview many topics are covered, starting with the philosophy and vision...
-
September 24, 2021 Interview with Trevor Millar, Advisor, NeonMind BiosciencesIn our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based...
